The Medication Safety Programme aims to reduce the number of New Zealanders harmed by medication errors and adverse drug events across the entire health and disability sector. Medication errors and adverse drug events affect an unacceptable number of New Zealanders each year, with some resulting in permanent disability or death.
The Medication Safety Programme is working to develop systems that prevent medication errors and adverse drug events. For the Medication Safety Programme to be successful, the support of the entire health and disability sector is needed.
While the programme has initially focused on hospitals and how they work with community-based care providers, it will also develop systems to allow the programme to extend across the entire sector.
The Medication Safety programme is guided by the Medication Safety Programme Governance Group which is accountable to the Commission and the National Health Board. The Medication Safety Expert Advisory Group (MSEAG) provides expert technical and clinical advice to the programme and the Medication Safety Steering Group manages and is accountable for project implementation.
The Commission employs a dedicated team working in the medication safety area. For information on our team members please click on the link below.
|Carmela Petagna - Senior Portfolio Manager
||Emma Forbes - Project Manager|
|Beth Loe - Medication Safety Specialist||Nirasha Parsotam - Medication Safety Specialist|
For any inquiries about Medication Safety please contact email@example.com.